Immunomodulatory treatment in multiple sclerosis: experience at a Brazilian center with 390 patients.


UNLABELLED Since 1993 the Federal Drug Administration approved the use of immunomodulatory therapy in multiple sclerosis (MS), modifying the natural course of disease, as demonstrate our experience in treatment of MS patients at the MS Treatment Center (CATEM). OBJECTIVE To evaluate patient behavior using immunomodulatory therapy for a period of five… (More)


5 Figures and Tables

Slides referencing similar topics